Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways

被引:78
|
作者
Ingram, Melissa [1 ,2 ]
Wozniak, Emily A. L. [1 ,3 ]
Duvick, Lisa [1 ,4 ]
Yang, Rendong [5 ]
Bergmann, Paul [6 ]
Carson, Robert [1 ,4 ]
O'Callaghan, Brennon [1 ,4 ]
Zoghbi, Huda Y. [7 ,8 ,9 ,10 ]
Henzler, Christine [5 ]
Orr, Harry T. [1 ,4 ]
机构
[1] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Minnesota Supercomp Inst, RISS Bioinformat, Minneapolis, MN 55455 USA
[6] Foresight Log Inc, Shoreview, MN 55126 USA
[7] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Dept Mol & Human Genet, Houston, TX 77030 USA
[8] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Dept Neurosci, Houston, TX 77030 USA
[9] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Dept Pediat, Houston, TX 77030 USA
[10] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA
关键词
SPINOCEREBELLAR ATAXIA TYPE-1; POLYGLUTAMINE-INDUCED DISEASE; AGONIST TETRAPEPTIDE; REPRESSOR CAPICUA; NERVOUS-SYSTEM; AXH DOMAIN; WILD-TYPE; EXPRESSION; CHOLECYSTOKININ; PROTEIN;
D O I
10.1016/j.neuron.2016.02.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
SCA1, a fatal neurodegenerative disorder, is caused by aCAG expansion encoding a polyglutamine stretch in the protein ATXN1. We used RNA sequencing to profile cerebellar gene expression in Pcp2-ATXN1 [82Q] mice with ataxia and progressive pathology and Pcp2-ATXN1[30Q]D776 animals having ataxia in absence of Purkinje cell progressive pathology. Weighted Gene Coexpression Network Analysis of the cerebellar expression data revealed two gene networks that significantly correlated with disease and have an expression profile correlating with disease progression in ATXN1[82Q] Purkinje cells. The Magenta Module provides a signature of suppressed transcriptional programs reflecting disease progression in Purkinje cells, while the Lt Yellow Module reflects transcriptional programs activated in response to disease in Purkinje cells as well as other cerebellar cell types. Furthermore, we found that upregulation of cholecystokinin (Cck) and subsequent interaction with the Cck1 receptor likely underlies the lack of progressive Purkinje cell pathology in Pcp2-ATXN1[30Q] D776 mice.
引用
收藏
页码:1194 / 1207
页数:14
相关论文
共 50 条
  • [1] The role of interruptions in the polyglutamine tract of ATXN1 in SCA1 pathology
    Nethisinghe, Suran
    Menon, R. P.
    Faggiano, S.
    Vannocci, T.
    Rezaei, H.
    Pemble, S.
    Sweeney, M. G.
    Davis, M. B.
    Wood, N. W.
    Pastore, A.
    Giunti, P.
    JOURNAL OF MEDICAL GENETICS, 2012, 49 : S91 - S91
  • [2] Combined overexpression of ATXN1L and mutant ATXN1 knockdown by MV rescue motor phenotypes and gene signatures in SCA1 mice
    Carrell, Ellie M.
    Keiser, Megan S.
    Robbins, Ashley B.
    Davidson, Beverly L.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 25 : 333 - 343
  • [3] Reduction of mutant ATXN1 rescues premature death in a conditional SCA1 mouse model
    Orengo, James P.
    Nitschke, Larissa
    van der Heijden, Meike E.
    Ciaburri, Nicholas A.
    Orr, Harry T.
    Zoghbi, Huda Y.
    JCI INSIGHT, 2022, 7 (08)
  • [4] Comparative Transcriptomic Analysis Identifies Rescue of Dysregulated Signatures by ATXN1 Knockdown and ATXN1L Overexpression in a Mouse Model of SCA1
    Robbins, Ashley
    Carrell, Ellie
    Keiser, Megan S.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2023, 31 (04) : 148 - 148
  • [5] Calcium dynamics and electrophysiological properties of cerebellar Purkinje cells in SCA1 transgenic mice
    Inoue, T
    Lin, X
    Kohlmeier, KA
    Orr, HT
    Zoghbi, HY
    Ross, WN
    JOURNAL OF NEUROPHYSIOLOGY, 2001, 85 (04) : 1750 - 1760
  • [6] Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1
    Nitschke, Larissa
    Coffin, Stephanie L.
    Xhako, Eder
    El-Najjar, Dany B.
    Orengo, James P.
    Alcala, Elizabeth
    Dai, Yanwan
    Wan, Ying-Wooi
    Liu, Zhandong
    Orr, Harry T.
    Zoghbi, Huda Y.
    JCI INSIGHT, 2021, 6 (03)
  • [7] Behavioral and pathologic characterization of SCA1 transgenic mice.
    Burright, EN
    Wilcox, C
    Duvick, LA
    Zoghbi, HY
    Clark, HB
    Orr, HT
    BEHAVIOR GENETICS, 1997, 27 (03) : 259 - 260
  • [8] Microarray analysis of gene expression in SCA1 transgenic mice.
    Serra, HG
    Byam, CE
    Lande, JD
    Tousey, SK
    Zoghbi, HY
    Orr, HT
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 338 - 338
  • [9] Molecular pathogenesis of a polyglutamine neurological disease: nuclear localization and aggregation in SCA1 transgenic mice
    Skinner, PJ
    Klement, IA
    Clark, HB
    Zoghbi, HY
    Orr, HT
    BRAIN RESEARCH, 1998, 809 (01) : A11 - A11
  • [10] Experience of mGluR1 Gene Therapy in Transgenic Models of SCA1 Mice
    Shuvaev, A. N.
    Hirai, H.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2016, 8 (04) : 143 - 156